RelB-dependent differential radiosensitization effect of STI571 on prostate cancer cells

Medicine and Dentistry

• Imatinib 100%
• Prostate Cancer 69%
• Cancer Cell 53%
• Cells 30%
• Androgen 30%
• Phosphotransferase 30%
• Therapeutic Procedure 15%
• Radiation Therapy 15%
• Phosphorylation 15%
• Phosphoinositide 3-Kinase 15%
• Development 7%
• Malignant Neoplasm 7%
• Gene Expression 7%
• Radiosensitivity 7%
• Gleason Score 7%
• Therapeutic Agent 7%
• Cytotoxicity 7%
• Binding Affinity 7%
• DNA Binding 7%
• Tyrosine-Kinase Inhibitor 7%
• Prostate Specific Antigen 7%

Pharmacology, Toxicology and Pharmaceutical Science

• Imatinib 100%
• Prostate Cancer 69%
• Phosphotransferase 30%
• Androgen 30%
• Ionizing Radiation 23%
• Radiation 15%
• Phosphatidylinositol 3 Kinase 15%
• Radiation-Induced Cytotoxicity 15%
• Malignant Neoplasm 7%
• Gleason Score 7%
• Protein Tyrosine Kinase Inhibitor 7%
• Prostate Specific Antigen 7%

Biochemistry, Genetics and Molecular Biology

• Cancer Cell 53%
• Radiation 46%
• Kinase 30%
• Phosphorylation 15%
• Cytotoxicity 15%
• Phosphoinositide 3-Kinase 15%
• LNCaP 15%
• Development 7%
• Gene Expression 7%
• Electric Potential 7%
• Radiosensitivity 7%
• Gleason Score 7%
• Contrast 7%
• DNA Binding 7%
• Binding Affinity 7%
• Tyrosine Kinase Inhibitor 7%
• Prostate-Specific Antigen 7%
• Methanesulfonic Acid 7%
• Imatinib 7%
• Radiosensitization 7%